374 related articles for article (PubMed ID: 16639033)
1. Dopaminergic neurons reduced to silence by oxidative stress: an early step in the death cascade in Parkinson's disease?
Michel PP; Ruberg M; Hirsch E
Sci STKE; 2006 Apr; 2006(332):pe19. PubMed ID: 16639033
[TBL] [Abstract][Full Text] [Related]
2. Neuronal pathology in Parkinson's disease.
Schulz JB; Falkenburger BH
Cell Tissue Res; 2004 Oct; 318(1):135-47. PubMed ID: 15365812
[TBL] [Abstract][Full Text] [Related]
3. Apoptosis and autophagy in nigral neurons of patients with Parkinson's disease.
Anglade P; Vyas S; Javoy-Agid F; Herrero MT; Michel PP; Marquez J; Mouatt-Prigent A; Ruberg M; Hirsch EC; Agid Y
Histol Histopathol; 1997 Jan; 12(1):25-31. PubMed ID: 9046040
[TBL] [Abstract][Full Text] [Related]
4. Intracellular signaling pathways involved in post-mitotic dopaminergic PC12 cell death induced by 6-hydroxydopamine.
Rodriguez-Blanco J; Martín V; Herrera F; García-Santos G; Antolín I; Rodriguez C
J Neurochem; 2008 Oct; 107(1):127-40. PubMed ID: 18665912
[TBL] [Abstract][Full Text] [Related]
5. Pathogenesis of nigral cell death in Parkinson's disease.
Przedborski S
Parkinsonism Relat Disord; 2005 Jun; 11 Suppl 1():S3-7. PubMed ID: 15885625
[TBL] [Abstract][Full Text] [Related]
6. Endoplasmic reticulum and mitochondria interplay mediates apoptotic cell death: relevance to Parkinson's disease.
Arduíno DM; Esteves AR; Cardoso SM; Oliveira CR
Neurochem Int; 2009 Sep; 55(5):341-8. PubMed ID: 19375464
[TBL] [Abstract][Full Text] [Related]
7. Embryonic stem cell-derived neuron models of Parkinson's disease exhibit delayed neuronal death.
Yamashita H; Nakamura T; Takahashi T; Nagano Y; Hiji M; Hirabayashi T; Amano T; Yagi T; Sakai N; Kohriyama T; Matsumoto M
J Neurochem; 2006 Jul; 98(1):45-56. PubMed ID: 16805795
[TBL] [Abstract][Full Text] [Related]
8. The MitoPark Mouse - an animal model of Parkinson's disease with impaired respiratory chain function in dopamine neurons.
Ekstrand MI; Galter D
Parkinsonism Relat Disord; 2009 Dec; 15 Suppl 3():S185-8. PubMed ID: 20082987
[TBL] [Abstract][Full Text] [Related]
9. Pathogenesis of Parkinson's disease.
Schapira AH
Baillieres Clin Neurol; 1997 Apr; 6(1):15-36. PubMed ID: 9426866
[TBL] [Abstract][Full Text] [Related]
10. Death in the substantia nigra: a motor tragedy.
Esposito E; Di Matteo V; Di Giovanni G
Expert Rev Neurother; 2007 Jun; 7(6):677-97. PubMed ID: 17563251
[TBL] [Abstract][Full Text] [Related]
11. Reversible inhibition of mitochondrial complex I activity following chronic dopaminergic glutathione depletion in vitro: implications for Parkinson's disease.
Chinta SJ; Andersen JK
Free Radic Biol Med; 2006 Nov; 41(9):1442-8. PubMed ID: 17023271
[TBL] [Abstract][Full Text] [Related]
12. K-ATP channels promote the differential degeneration of dopaminergic midbrain neurons.
Liss B; Haeckel O; Wildmann J; Miki T; Seino S; Roeper J
Nat Neurosci; 2005 Dec; 8(12):1742-51. PubMed ID: 16299504
[TBL] [Abstract][Full Text] [Related]
13. Detrimental deletions: mitochondria, aging and Parkinson's disease.
Biskup S; Moore DJ
Bioessays; 2006 Oct; 28(10):963-7. PubMed ID: 16998822
[TBL] [Abstract][Full Text] [Related]
14. Mitochondria, calcium, and endoplasmic reticulum stress in Parkinson's disease.
Calì T; Ottolini D; Brini M
Biofactors; 2011; 37(3):228-40. PubMed ID: 21674642
[TBL] [Abstract][Full Text] [Related]
15. Oxidative stress and inflammation in Parkinson's disease: is there a causal link?
Hald A; Lotharius J
Exp Neurol; 2005 Jun; 193(2):279-90. PubMed ID: 15869932
[TBL] [Abstract][Full Text] [Related]
16. Interaction of alpha-synuclein and dopamine metabolites in the pathogenesis of Parkinson's disease: a case for the selective vulnerability of the substantia nigra.
Galvin JE
Acta Neuropathol; 2006 Aug; 112(2):115-26. PubMed ID: 16791599
[TBL] [Abstract][Full Text] [Related]
17. Curcumin treatment alleviates the effects of glutathione depletion in vitro and in vivo: therapeutic implications for Parkinson's disease explained via in silico studies.
Jagatha B; Mythri RB; Vali S; Bharath MM
Free Radic Biol Med; 2008 Mar; 44(5):907-17. PubMed ID: 18166164
[TBL] [Abstract][Full Text] [Related]
18. Revisiting oxidative stress and mitochondrial dysfunction in the pathogenesis of Parkinson disease--resemblance to the effect of amphetamine drugs of abuse.
Perfeito R; Cunha-Oliveira T; Rego AC
Free Radic Biol Med; 2012 Nov; 53(9):1791-806. PubMed ID: 22967820
[TBL] [Abstract][Full Text] [Related]
19. [Mechanism of cell death in neurodegenerative disorders: apropos of Parkinson disease].
Agid Y
C R Seances Soc Biol Fil; 1993; 187(1):37-46. PubMed ID: 8242421
[TBL] [Abstract][Full Text] [Related]
20. Neuronal vulnerability in Parkinson's disease.
Double KL
Parkinsonism Relat Disord; 2012 Jan; 18 Suppl 1():S52-4. PubMed ID: 22166454
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
